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Abstract

Background: Medicare spends $17 billion yearly on 30-day readmissions. Hispanic adults
have a higher prevalence of diabetes (12.6%) compared to non-Hispanic whites (9.4%).
Those with a diagnosis of diabetes have the 17% higher rate (14-23%) for 30-day
readmission. Little research has been conducted on Hispanics with diabetes relative to 30-day
readmissions.
Aims: Among Hispanics with type 2 diabetes: 1) measure the incidence of 30-day
readmission by sociodemographic, behavioral and clinical factors;2) identify independent
factors associated with 30-day readmission among Hispanic adults with type 2 diabetes
accounting for potential covariates; 3) compare the ability of the Hispanic Diabetic Study
Model plus ED, to the LACE model.
Methods: The overall 30-day readmission rate for the three years of 14.7% (N=5985)
and for those in the study cohort of 9.5% (N=3865). The Hispanic-Diabetic model plus
ED had ACU of 0.67 with a high specificity of 99.5% and low sensitivity of 5%.
However, the PPV (positive predictive value) was 57.4%, much better than 9.5%.
Findings: The readmission rate in the cohort declined from 11.8% to 9.5% over time indicate
studied hospital has purposefully worked to decrease 30-day readmissions and have been
successful among Hispanics with diabetes. Employment status: only 15% were employed,
disabled (20%) had an adjusted odd of 2.43, retired (49%, adj 1.68) increased odds of
readmission. The number of ED visits prior to admission was the strongest predictor ranging
from an adjusted odd of 6.04 for 1 visit to 14.56 for 3 visits. The length of stay OR=1.75 for
4-6 days or an increase of 5% odds for every day in the hospital and smoking marginally
increased odds of readmission. Receiving a consult for a home health aide at discharge was
an important factor. Surprisingly, the diabetes complications code decreased the odds of 30day readmission even though HgA1C above 9% did slightly increase odds. The majority
were Spanish-speaking (69%), and 70% of all participants were seen by a diabetes nurse
practitioner.
Implications: Identified key factors of 30-day readmission among Hispanics with diabetes
may lead to future targeted interventions effective in reducing readmissions in this
population.
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CHAPTER ONE
Introduction

The prevalence of type 2 diabetes in the United States has more than tripled, increasing from
3% in 2000 to 9% in 2017 or 30.3 million people (Centers for Disease Control and
Prevention [CDC], 2017). The American Diabetes Association (ADA) recently estimated the
cost of diabetes at $327 billion in 2017, a 33% increase in the last 5 years. (ADA, 2018).
This equates to a per capita health cost 2.3 times higher for those with disease compared to
those without (ADA, 2018). Additionally, diabetics account for 25% of all hospital and
nursing home stays. (Hass, 2014)
Adult Hispanics are 1.7 times more likely to become diabetics than non-Hispanic
Caucasians (CDC, 2017). Therefore, a disproportion of hospital admissions with be among
Hispanics with type 2 diabetes especially in regions where a large proportion of the
population is Hispanic. Having a large proportion of Hispanic diabetic patients may pose a
problem to hospitals and providers due to language barriers, cultural tradition related to food
and exercise, and possible differences in decision-making among the family (Corrigan &
Martin, 1992; Katzmarzyk, & Staiano, 2012).
Therefore, this study aims to identify, explore, and describe factors related to 30-day
readmission among a large sample of Hispanic adults with type 2 diabetes. Findings can
serve as a foundation for designing potential interventions to reduce these readmissions.
Chapter one reviews the scope and significance of 30-day readmission among Hispanics
adults with type 2 diabetes.
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Scope and Significance
Despite advanced efforts in preventative medicine, diabetes remains the seventh leading
cause of morbidity and mortality in the United State (CDC, 2017). Fortunately, the overall
death rate from diabetes has decreased significantly over the past 20 years because of
advancements in medicine (McBean et al., 2004). The prevalence of diabetes is expected to
increase by 54%, which means by 2030 54.9 million people will be diagnosed with type 2
diabetes (Rowly, Bezold, Artikan, Byrne, & Krohe, 2017). This is a critical issue to consider
for future generations as more people become diabetic.
Hispanic-Americans are the fastest growing segment of the population in the United
State (Rowly et al., 2017) and they have a higher prevelence of diabetes. Among U.S.
Hispanics, 12.6% have type 2 diabetes compared to 7.1% of Caucasian non-Hispanics (CDC,
2017). The Hispanic diabetic population is also younger than diabetics of other ethnicities
(CDC, 2017). By 2030, the number of Hispanics with type 2 diabetes is expected to increase
93%, reaching 13.1 million people (Rowly et al., 2017). This will result in concurrent health
care cost increases. By contrast, African-Americans, the second largest minority group in the
U.S., are expected to see a 51% increase in diabetes diagnosis.
Providing hospital care for patients with a 30-day readmission can be very expensive
for hospitals. The Centers for Medicare and Medicaid Services (CMS) reduce hospital
reimbursement if a Medicare participant is readmitted within 30 days (McIlvennan, Eapen, &
Allen, 2015). The CMS reports U.S. hospitals paid $528 million in penalties for patients
readmitted within 30 days of discharge in 2017 (Boccuti & Casillas, 2017). Twenty percent
of Medicare beneficiaries experience 30-day readmissions, costing Medicare more than $17
billion annually (Zohrabian, Kapp, & Simoes, 2018; McIlvennan et al., 2015). The CMS also
2

3

monetarily penalizes hospitals with higher-than-expected readmissions by withholding
additional reimbursement funds (Zohrabian, Kapp, & Simoes, 2018; National Quality Forum
2015-2017). Also, increasing 30-day readmissions negatively affects a hospital’s quality of
care rating if that figure is above the accepted rate for specific diagnoses (McIlvennan et al.,
2015). Thirty-day readmission rates for type 2 diabetes are 14 to 23% in comparison to all
other hospitalized patients at 8.5to 13.5% (Ostling et al., 2017). The present study aims to
address this issue.
Potential Factors Related to 30-day Readmission
A diagnosis of type 2 diabetes often complicates hospitalizations associated with
diagnoses such as myocardial infarction, congestive heart failure, or pneumonia, (Jiang et al.,
2005). Enomoto and colleagues reported that length of hospitalization is five days or longer
among patients with type 2 diabetes compared to non-diabetics who stay on average two days
or less. Also, they reported diabetics have a 17% greater chance of readmission within 30
days compared with non-diabetic patients hospitalized (Enomoto et al., 2017). Few studies
have focused on hospitalizations among Hispanics with type 2 diabetes, and even fewer have
examined their 30-day readmissions rate and causes (Dungan, 2012; Spanakis & Golden,
2014). Reasons for increased hospitalizations among Hispanics may be related to both social
determinants of health and health care access. Income is highly associated with mortality and
morbidity. One in five Hispanics (20%) live at or below the poverty level (CDC, 2017).
Low income combined with living in poorer neighborhoods with less access to nutritious
food, having lower levels of educational attainment, lower English literacy, and also less
health literacy, all have been identified as risk factors for readmission and can affect diabetes
management. These factors, especially immigrant status, in turn can lead to decreased
3
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primary care health access which may mean poorer glucose control leading to
rehospitalization. Disparities in social determinants may also mean higher rates of
undiagnosed diabetes. A study examined differences in health care services usage among
diabetics by ethnicity using propensity scoring to adjust for notable sociodemographic and
behavioral differences between Hispanics and non-Hispanics (Lai et al., 2017). Even with
these adjustments, Hispanics who are hospitalized for other illnesses, have an increased risk
of being diagnosed with diabetes for the first time (Lai et al., 2017). Lai and colleagues
showed Hispanics had less office visits with a provider, had more prescribed medication but
less medication was purchased or used. These factors are reflected in the higher than average
hospital costs for Hispanics $3918 compared to $ 2846 non-Hispanics (t (116) =5.99,
p=0.001) (Lai et al., 2017).
For Hispanic patients, the hospital stay may not be long enough or the care is
insufficiently coordinated so they are not confident in monitoring and managing their glucose
levels and diet on discharge. Patients newly diagnosed with diabetes are at increased risk for
readmission (Rubin, 2015). Post-discharge, if they do not have an identified primary care
provider to see soon after discharge, they are also at increased risk for readmission (Dungan,
2012; McIlvennan et al., 2015). One study identified that Hispanics from lower
socioeconomic levels with diabetes in their study had the higher risk for 30-day hospital
readmission (Rubin, 2015).
Study Population
This study will use data from a community hospital that serves the South Region of
San Diego County. This region includes the Health Service Areas of Coronado, National
City, Chula Vista, Sweetwater, and South Bay. Due to its proximity to the Mexican border,
4
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this area has a high proportion of Hispanics. Of its nearly half million residents, 60% or just
over 300,000 are Hispanic, the largest proportion of Hispanic in San Diego County (SD
County 2018). The most recent community health needs assessment identified that diabetes
related hospitalizations, emergency department discharges, and deaths among Hispanics were
disproportionately higher in this region compared to Hispanic in other regions. (SD County
2014).
Although some studies examining risk factors for 30-day readmission among type 2
diabetics have examined factors such as sociodemographic and race/ethnicities, in general
these studies contained very small samples of Hispanic patients (Aponte & Nokes, 2017;
Rubin et al., 2014; Dungan, 2012; Enomoto et al., 2017; Jiang et al., 2005; Robbins &Webb,
2006; Rubin, 2015). Since data will come from a community hospital in an area serving a
large Hispanic population, it will be able to focus solely on 30-day hospital readmission risk
factors among Hispanics with type 2 diabetics.
Purpose
This retrospective case control study aims to identify factors associated with 30-day
readmission among Hispanics with type 2 diabetes.
Research Aims
The following research aims was addressed:
Specific Aim 1: Measure the incidence of 30-day readmission among Hispanic adults with
type 2 diabetes in a community hospital.
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Specific Aim 2: Identify factors associated with 30-day readmission among
Hispanics with type 2 diabetes.
Specific Aim 3: Compare the ability of two different models to predict 30-day
hospital readmissions among Hispanic diabetics:
•

Model 1: LACE score index

•

Model 2: Model developed from the study data which includes novel
variables added into the LACE index.
Summary
This chapter focused on the problem of 30-day readmission among Hispanic adults

with type 2 diabetes. This problem is amplified by the increasing prevalence of type 2
diabetes in the United States, particularly among Hispanics, and the rise in the proportion of
Hispanics in the population. The 30-day readmission of Hispanic with type 2 diabetes
presents a major health care and economic problem for patients and hospitals, especially
those with high Hispanic populations. Factors that the literature describes as particularly
relevant to 30-day readmission include Hispanic ethnicity, increased length of stay during the
primary hospitalization, non-Caucasian race, low social-economic status, age, low levels of
education, lack of access to care, higher comorbidity and cultural barriers.
The scope and significance of 30-day readmissions among Hispanics with type 2
diabetes along with lack of research in the area of identifying factors that may predict 30-day
readmissions provides justification for the proposed study. In the next chapter, a review of
the literature explores factors contributing to 30-day readmissions among Hispanics with
type 2 diabetes and presents a conceptual framework for the study.
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Chapter 2
Review of Literature
Introduction
Chapter 1 discussed the scope of the problem of diabetes among the Hispanic community, its
consequences and its causes, as well as the health care costs. This chapter will describe the
literature on hospital 30-day readmissions in general with a particular focus on those studies
that may have included a significant subset of Hispanic patients. This will be followed by a
review of studies focused on early readmission of patients with diabetes, again with a focus
on the sub-population of Hispanics. Other literature will then be reviewed to cover factors
for inclusion in the proposed study that have not been included in the hospital readmission
studies of diabetes. Lastly a conceptual framework for the proposed study will be presented.
The chapter ends with a summary and clear justification for the proposed study.
General 30-day Readmission Studies
As previously described diabetes is one of the fastest growing chronic diseases with
Hispanic Americans having the fastest rising prevalence. Therefore, the number of patients
admitted with diabetes, as a primary or secondary diagnosis, is likely to grow above the
current 7.2 million hospital discharges with a diabetes diagnosis (Centers for Disease Control
and Prevention[CDC], 2017). Diabetes can not only complicate hospitalization, but also
involve the need for coordinated care post-hospital discharge. Understanding the risk factors
that result in Hispanics being re-hospitalized is important to develop better targeted hospital
discharge interventions to save hospital’s money and to improve patient outcomes.
Kaiser Readmission Study
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A study of 30-day hospital readmission using all 18 hospitals in the Northern California
Kaiser system identified diabetes as the second leading cause of readmission at 30%, just
after hypertension at 36%. Readmissions related to heart failure and cardiovascular disease
were lower in this study, at 20% and 19% respectively (Feigenbaum et al., 2012). The
Feigenbaum et al. (2012) study was limited due to the fact that everyone was eligible for
Kaiser insurance as well as the lack of variation in race/ethnicity of those studied, 67% were
non-Hispanic white and only 9% were Hispanic.
Nevertheless, Feigenbaum et al. (2012) provided important data regarding preventing
30-day readmissions among patients with type 2 diabetes. Feigenbaum et al. (2012) showed
that 47% of the 30-day readmissions may have been preventable, 36% were moderately
preventable, and 11% were completely preventable. The researchers narrowed preventable
factors of 30-day readmissions into the following three categories: 1) quality of care during
hospital stay 30-day readmission; 2) ineffective discharge process increased 30-day
readmission; and 3) missing or late follow-up care after discharge from the hospital increased
30-day readmission (Feigenbaum et al., 2012).
Feigenbaum et al., (2012) found preventable readmissions were caused by sub-optimal
management of a chronic condition (80%), transitions of care problems (73%) and lack of
referral for advance care planning and end-of-life care (41%). Feigenbaum et al., (2012)
suggested since diabetes can be difficult to manage, especially among those hospitalized, this
may indicate the need for better care coordination for patients with diabetes during hospital
stay and post discharge using current and new tactics.
Predictive Models for 30-day Readmission
Kansagara and colleagues (2011) systematically reviewed 7843 studies, with the
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number of participants ranging from 173 to 3 million, to investigate factors predicting
readmission risks among hospitalized patients. Fourteen of these studies only chose patients
65 and older and half of these studies only accepted Medicare participants and Veterans. Of
these 30 studies, the majority (23) were performed in the US and seven others were
conducted in five other western countries.
Kansagara and colleagues (2011) found 26 models that predicted readmission risks in
30 different studies. All 26 models included comorbidities and previous hospitalizations, but
variables that were not addressed, that could be useful markers, were social determinants of
health, mental health, functional status, and disease severity.
They reported that one model was unique in that it addressed preventable
readmissions. Fourteen models measured risk for readmission using retrospective hospital
data. Five models used prospective data (up to discharge) during recent hospitalizations (cstatistic=0.68-0.83). Nine models with large populations did not statistically predict
readmission (c-statistic =0.55-0.65). They concluded that seven models could be used early
in a hospital stay for early intervention (c-statistic =0.56-0.72). A c-statistic less than 0.5 is
not significant, 0.7-0.8 is modest or acceptable, and greater than 0.8 indicates good
discriminative ability. Six of the models compared functional and social variables within the
same group of patients thus improving discrimination related to readmission (Kansagara et
al., 2011). A simple Canadian model had good predictability (c-statistics =0.68) of 30-day
readmissions, using comorbidities, length of stay, and prior hospitalization (Kansagara et al.,
2011). A polypharmacy variable was used in an Irish model with strong predictability (cstatistics =0.7). Another model found inclusion of medical comorbidity, prior hospitalization,
and creatinine level at discharge increased risk of readmission among heart failure patients
9
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(Bradley et al., 2013; Kansagara et al., 2011). The Center for Medicare and Medicaid
Services (CMS) tested three models and found poor predictability for 30-day readmissions
for myocardial infarction (c-statistics=0.63), pneumonia (c-statistics =0.63) and congestive
heart failure (c-statistics=0.61) (Kansagara et al., 2011).
Most models did not significantly predict 30-day readmission (5-79%) (Kansagara et
al., 2011). The systemic review of 34 studies showed that while one model may serve as a
strong predictor of readmission for one condition, it may be a poor predictor for another.
Also, to increase a model’s predictability, the model must focus on a specific population. For
example, even though comorbidity may fit in a model, social determinants maybe a better fit
for disadvantaged populations (Kansagara et al., 2011).
Complexity of Diabetes Care Possibly Affecting Readmission
Managing diabetes is challenging because diabetes is a chronic and complex illness
that is influenced by a variety of personal factors. Furthermore, physical functioning and
cognitive abilities are extremely important for performing needed self-care activities. For
example, patients who are unable to perform insulin injections due to stroke or vision
changes may be more at risk for hyper- or hypoglycemia (Dungan, 2012). The diabetic
patient’s level of education, experience, and skills have a direct effect on self-care
maintenance; motivation to get involved in their own care is either intrinsic or extrinsic (
Dungan, 2012; Stellefson et al., 2013). A patient’s cultural beliefs and values also are
important in this initial stage. For example, if the patient believes his aunt lost her eyesight
from insulin, this belief would directly affect his willingness to be put on insulin in the
hospital and its use at home (Galanti, 2014). Self-care maintenance also involves the
patient’s level of confidence to become involved in his or her own care (Stellefson et al.,
10
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2013). Woolf and Braveman (2011) reported that race and ethnicity, level of education, and
income affect health status and health disparities among those with type 2 diabetes and
increases the odds of 30-day readmissions. Indiviudals with lower socioeconomic status may
need more education and coaching to achieve good glycemic control.
30-day Readmission for Patient with Diabetes Studies
Several studies have found a higher risk of 30-day readmissions among patients with
type 2 diabetes than among non-diabetic patients. Rubin (2015) reported 30-day
readmissions were higher among patient with diabetes compared to non-diabetics (15.3% vs.
8.4% respectively, p < 0.001) and similar findings have been reported in similar studies
(14.4–22.7% vs. 8.5–13.5%) ( Sonmez, Kambo, Avtanski, Lutsky & Poretsky, 2017). Jiang
et al., (2005) and Feigenbaum et al. (2012) reported around 30% of patients with type 2
diabetes have multiple 30-day readmissions.
Diabetes Early Readmission Risk Indicator (DEERI)
Rubin and colleagues focused on developing a Diabetes Early Readmission Risk
Indicator (DEERI) to identify patients at highest risk for readmission (2016). Over 44,000
discharges among slightly more than 17,000 patients in Boston, MA over an eight-year
period were used for the study. They used 60% of the cohort as the training sample and 40%
to validate the tool. Twelve percent of the population of this study were Hispanics and 19%
did not speak English. The 30-day readmission rate for this cohort was 20.4%. They
examined 46 predictor variables for building their risk tool. The final DEERI contained 10
predictor variables that were the most significant predictors of hospital readmission. These
consisted of two socio-economic status (SES) variables: zip code within 5 miles of the
hospital and employment status. The latter had the highest associated odds ratios of all model
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variables with disabled status odds ratio (OR) of 1.94 (95% CI 1.63, 2.32) and unemployed
status OR 1.52 (95% CI 1.28, 1.80). Two model variables related to diabetes on admission:
use of insulin, and presence of stage three or higher macrovascular disease. Another
admission variable, presence of anemia, also stayed in the model. Two variables related to
prior hospital discharges were in the model: prior discharge within 90 days of admission and
if within the prior year the patient was discharged against medical advice. The remaining
three variables related to clinical laboratory values of serum sodium, creatinine, and
hematocrit. The c-statistic for the model was 0.70 indicating a good but not strong model.
The model had a mean 30-day prediction of 39% for the highest quintile of scores and
predicted about 38% of 30-day readmissions.
Rubin and colleagues (2018) sought to validate the DEERI tool with a different
population of nearly 106,000 discharges among 19,000 patients. This population had a 30day readmission rate of 18%. They obtained similar results with the exception that A1C and
cholesterol levels were significant predictor variables but their inclusion in the model did not
improve the c-statistic of 0.634. Rubin and colleagues conducted a third study among patient
with diabetes with cardiovascular disease (2017). This study had very similar findings as to
significant predictors, however education became a significant predictor variable. This
study’s population included 9% Hispanics.
Jiang, Stryer, Friedman, and Andrews (2003) used utilization review and healthcare
cost data of over 648,000 patients with diabetes hospitalized in California, Missouri, New
York, Tennessee, and Virginia in 1999. Their study showed Hispanics diabetics had
increased odds for 30-day readmission (OR=1.2 ;1.18-1.23) compared to white non-Hispanic
diabetics controlling for age, sex, payer, location, and income. They reported a
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rehospitalization rate for Hispanics of 37.2% compared to 34% for non-Hispanic blacks and
31% for non-Hispanics whites. Their study also showed higher rate of 30-day readmission
among those insured by Medicare (OR=1.48; 1.45-1.50) or Medicaid ( OR=1.63; 1.60-1.66)
as well as families living in low income area. There was a high rate of comorbidities among
these hospitalized diabetic patients: 90% had cardiovascular disease, 40% had lower
extremity disease, and 25% had renal disease.
Their study findings are consistent with others have found that Hispanics and nonHispanic blacks with diabetes have the highest rates for 30-day readmission, end stage renal
disease, cost of hospitalization, and are less likely to have had a HgA1C drawn within
hospital saty, a yearly eye exam, a podiatry exam or to self monitor their glucose levels
(Dugan, 2012). Therefore, Hispanics and non-Hispanic blacks with diabetes more likely to
have poor glycemic controlled (Jiang et al., 2005; Dungan, 2012).
Enomoto and associates (2017) did a retrospective study using the Pensylvania
Healthcare Cost Containment Council data from 2011-2012 related to 30-day readmission
and length of stay (LOS) among type 2 diabetics. Patient with diabetes were 17% more likely
to be readmitted within 30-days post discharge from the hospital, (AOR=1.17, P<0.001) and
had a longer length of stay (LOS) (0.19 days, P<0.001) and were more likely to stay longer
than 5 days (AOR=1.71, 95% CI; 1.66-1.75) (Enomoto et al., 2017). Their study showed
patients with diabetes were more likely to be readmitted for infectious complications (9.4%
vs. 7.7%), heart failure (6.0% vs. 3.1%), and chest pain/myocardial infarction (MI) (5.5% vs.
3.3%) than patients without type 2 diabetes.
Enomoto and associates (2017), like previous studies, identified advanced age, male
gender, non-white race (black), Medicare insurance, transfer another hospital increased the
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rate of 30-day readmission among patients with diabetes. Diabetes increased the number of
comorbidities similarly to Dugan (2012) such as MI, stroke, malignancy, liver and renal
failure. Enomoto and colleagues (2017) study was limited to Pensylvania, decreasing its
genralizability. Even though their findings were similar to other studies, they may not be
generalizable to a largely Hispanic population. It has been suggested due to importance the
attenction has been placed to decrease 30-day readmmission among patient with diabetes
each medical center should run their own study to evaluate causes of 30-day readmission
uniqe to their population.
Social Determinants of Health
Understanding the social determinants of health is critical for understanding the root
cause for health problems and developing effective health interventions (Walker,
Gebregziabher, Martin-Harris, & Egede, 2014). Healthy People 2020 highlights the
importance of social determinants of health. Having access to high quality healthcare,
nutritional food, higher education, health literacy, and living in a safe neighborhood with
quality housing are social determinants of health that directly and indirectly affect type 2
diabetes management (Castañeda et al., 2015; Hill, Nielsen, & Fox, 2013). Adverse social
determinants of health have been associated with the increased incidence of type 2 diabetes.
A low level of education and poor living conditions, including unsafe neighborhoods and
communities, negatively impact a patient’s health, especially those with chronic, complex
conditions like type 2 diabetes (Woolf & Braveman, 2011). Woolf & Braveman (2011)
noted that to close the gap on health disparities, these root causes must be addressed.
In 2004, Brown and colleagues sought to explain the mechanisms of connecting
socioeconomic factors and social determinats of health in patient with diabetes (Brown et al.,
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2004; Walker et al., 2014). They found that individual, household, and neighborhood
socioeconomic status were predictors of general and specific diabetes outcomes. Moreover,
social determinants of health, including race, ethnicity, income, education level, language
ability and health literacy, and insurance status affect the quality of care processes and
outcomes in type 2 patient with diabetes (Woolf & Braveman, 2011). Unfortunately, there
are a limited number of Hispanic health care providers who may be able to provide care in a
Hispanic patient’s preferred language and may have a better understanding of cultural issues
that are promoters or barriers to self-care and treament (Castañeda et al., 2015).
Other social determinants such as psychosocial influences are also important when
investigating diabetes self-care (Brown et al., 2004; Hill et al., 2013; Walker et al., 2014).
Brown et al. (2004) explained that individuals with type 2 diabetes are affected by the
environmet in which they were born, live, play, work, and age. They believed that the
individual’s enviroment dictated their diabetes outcome. These are associated with glycemic
control both directly and indirectly through self-care, access to care, and processes of care.
In studying Hispanics in Southern California, immigration is a social determinant of
health that cannot be ignored. In the last 40 years, Hispanics, from Mexico specifically, were
the largest population of immigrants into the United States (Greieco, 2010). Type 2 diabetes
rates in Mexico have risen significantly from 6.7% in 1994 to 14.4% in 2006 (Barquera et
al., 2013). Afable-Munsuz and colleagues (2013) reported on the relationship between
generations of immigrants, acculturation, and their risk of diabetes. Relative to firstgeneration Mexican-American adults, the odds of second-generation Mexican-American
adults having type 2 diabetes is 1.8, [95% CI 1.4, 2.4) and increases to 2.1, 95% CI (1.4, 3.1)
in the third-generation (Afable-Munsuz et al., 2013). This is especially important to the area
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of San Diego, adjacent to the border, which has a large population of Hispanic adults with
type 2 diabetes.
A significant proportion of these Hispanic immigrants are undocumented which restricts
their access to health care and jobs. Due to these factors, they suffer from lower income, lack
of transportation and have high life stressors including hunger and homelessness (Chavez,
2012; Keusch, Wilentz & Kleinman, 2006). All of these result in underutilization of health
care and when accessed, an inability to pay for drugs, including insulin which has become
quite expensive. Horton and Barker (2010) reported a lack of access to proper medical care
for young Mexican-Americans could cause long-term negative social effects, which they call
“stigmatized biologies”.
Nurses, Diabetes-NPs, and Hospitals as Determinants of Care
In addition to patient, family, and social determinants of health, researchers have found
that nurses, diabetes nurse practitioners, other healthcare providers, and hospitals greatly
impact patients with diabetes’ initial, maintenance, and long-term status as they live with this
chronic illness. Although nurses and diabetes nurse practitioners must be cognizant of
patient, family, and social determinants and health-care sytem affecting diabetic patients,
diabetes nurse practitioners greatest impact is at the bedside administering care, juggling to
achieve precise and cost-effective treatment that is specific to each patients’ needs among
type 2 diabetics. Diabetes nurse practitioners play a major role in improving the life of
patients with diabetes during their hospitalization; and after discharge. Kaplan and his
colleagues (1987) noted that positive social support increases diabetic patients’ satisfaction
and also has a positive impact on improving A1C, especially among females (Kaplan et al.,
1987). Nurses and diabetes nurse practitioners are the professionals focused on providing this
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social support. One study demonstrated that diabetes nurse practitioners obtained good longterm glycemic control and high patient satisfaction while providing diabetes management to
hospitalized patients for cardiovascular diagnosis (Li et al., 2017)
In many cases, patients insured or unisured receive their diabetes diagnosis in the
hospital for the first time while admitted for other diagnosis (Dugan, 2012). Studies suggest
that to decrease 30-day readmissions related to type 2 diabetes, hospitals must create cost
effective quality improvement and supportive interventions while patients are still in the
hospitals (Jack et al., 2009; Dugan, 2012). Researchers agree that patients’ self-management
begins with good glycemic control in the hospital (Moghissi et al., 2009; Dugan, 2012).
Good glucose management during hospitalization decreases the risk of 30-day hospital
readmission (Dugan, 2012), During hospital stays, hyperglycemic episodes cause an
increased risk of complications and mortality, with or without, prior diagnosis of diabetes
(Corsino et al., 2017). Evidence shows that excellent glycemic control during the hospital
stay affects the patient’s self-management even after discharge from the hospital (Moghissi et
al., 2009; Dugan, 2012; Corsino et al., 2017).
These facts provide evidence for assigning a diabetes team to monitor and manage blood
glucose to ideal levels of euglycemia. This should greatly decrease length of stay and 30-day
readmission (Moghissi et al., 2009; Dugan, 2012; Corsino et al., 2017). On the other hand,
very poor glycemic control (HbA1c > 10%) may lead to impaired immune function
associated with post-operative infection and increased readmission among surgical diabetic
patients (Dungan, 2012; Furnary, Wu & Bookin, 2004; Rogers et al., 2008; Turina, Fry &
Polk, 2005).
Another important hospital system factor is the replacement of primary care providers
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with hospitalists who only care for patients in the hospital. The hospitalists’ job ends upon
patient discharge, which may decreases type 2 diabetics’ medication compliance (Poghosyan
et al., 2017; Jack et al., 2009). This may be problematic for two reasons. First, medication
lists while in the hospital must be changed to decrease drug-drug interaction with inpatient
treatment during hospital stay. Medications that should be taken at home may have wider
safety margins given less medical supervision at home. Sometimes hospital’ medication
discahrge lists are not changed to reflect what the patient should take at home causing
patients to take potentially harmful medications or dosages which in turn can trigger mistrust
and nonadherence to medical recommendations (Poghosyan et al., 2017). Lack of medication
reconciliation can be a combination of a system-problem and a provider problem as can the
fact many of these patients lack knowledge about their hospital diagnosis, understand the
purpose of all thier medications (Jack et al., 2009). Secondly, follow-up visits missing
critical information increase when type 2 diabetic patients are transferred to subsequent
nursing home facilities or other providers affecting the quality of complex diabetes
management and the patient’s safety (Poghosyan et al., 2017; Jack et al., 2009).
The Affordable Care Act improved accessibility to care and helped patients obtain
health insurance at a lower price. However, a high deductible for prescription medication
remains an issue when patients have to pay full price for insulin at the pharmacy counter
since insulin has no generic form (Lipska et al., 2014). In 2002 a vial of insulin cost $40,
today it cost nearly $300, 7.5 times more. One study found one in four patients on insulin
reported cost-related underuse which correlated with poorer glycemic control (Harkert,
2018). Out of pocket cost for patients with private insurance in one endocrinologist office’s
study has increased by 89% in 10 years (Lipska et al., 2014). A decrease in the price of
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prescription drugs, in this case insulin, would improve HgA1C levels and medicinal
adherence, which positively affects wellbeing and decreases the possibility of 30-day
readmission (Dugan, 2012). Diabetes nurse practitioners and other providers must strike a
balance between prescribing the best medication for their patients and what they can afford.
Cost effective quality improvement interventions, such as having an inpatient diabetes
team, lead to decreased emergency room visits for patients with type 2 diabetes-related
complications (Jack et al., 2009). Also, follow-up visits with providers, such as diabetes
nurse practitioners or primary care physicians who are familiar with the patient’s case during
the hospital stay, and immediately after discharge, would likely have a huge impact on
decreasing 30-day readmissions related to type 2 diabetes, and imrove patient satisfaction
scores (Jack et al., 2009; Wachter, 2004; Moore et al., 2003).
Most studies related to 30-day readmission have focused on specific diagnoses like
congestive heart failure or diabetes; or on high risk groups like elderly patients (Anderson et
al., 2005; Phillips et al., 2004; Jack et al., 2009). Elderly patients are more likely to be
readmited within 30 days from discharge because of advanced age and living with diabetes
complications (Coleman et al., 2006; Jack et al., 2009). Few studies have focused on
important aspects of discharge planning such as access to care; the ability to follow-up with a
diabetes nurse practitioner or primary care physician in a timely manner post hospital
discharge idealy within 10-14 days after discharge (Jack et al., 2009) smooth transition of
care after discharge with clear discharge instructon in patiet-approprate language and
delivery system (Jack et al., 2009); or increase patients′ ability to care for themselves after
discharge because of their complex treatment regimen of type 2 diabetes with creating
excelent teaching envorinment during hospital stay (Coleman et al., 2006).
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Some hospitals have implimented transition-of-care teams (Dugan, 2012). This service
allows the patient after discharge to keep a continuous flow of care between discharge and
primary care visit in the event the patient cannot get an appointment with primary care
immediately after discharge (Garnica, 2017; Kripalani, Jackson, Schnipper & Coleman,
2007; Kripalani et al., 2014).
Other Factors Affecting Readmission
One way to improve 30-day readmission among patient with diabetes is with better glucose
management during their hospital stay (Dugan et al, 2012). Researchers and endocrinologists
have shown increased rates of morbidity and mortality, and higher health care costs are
associated with uncontrolled blood glucose during hospitalization (Moghissi et al., 2009;
Dugan, 2012). Moghisssi et al., (2009) defined hyperglycemia as blood glucose over 180
mg/dl and hypoglycemia as below 70 mg/dl. Hyperglycemia was noted in 32.3% of all
critically ill patients and 22-46% of all non-critically ill patients (Clement & Braithwaite,
2004; Corsino et al., 2017).
Family has both a direct and an indirect effect on diet, exercise, and self-care
management among adults with type 2 diabetes (Wen, Shepherd & Parchman, 2004).
Healthcare providers must involve the family in the management and support of patient with
diabetes, especially with elderly patients with type 2 diabetes (Wen, et al., 2004). To improve
diabetes self-management, Wen and colleagues recommend diabetes interventions focus on
family support directed towards patient self-care, self-efficacy, and removing barriers to care.
Sharifirad et al., (2013) showed type 2 diabetes patients’ glycated hemoglobin A1C improved
with family support and increased self-efficacy.
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Mayberry and Osborn (2012) performed a mixed-methods study to examine the
effects of family support on patients’ diabetes medication adherence and glycemic control.
Their results revealed family members with more knowledge of type 2 diabetes self-care
were better able to support the patient in self-care management and medication adherence in
the long run decreasing 30-day readmission and complications related to diabetes. In
contrast, patients with non-supportive families were less likely to adhere to diabetic
medications, resulting in worsening glycemic control. Interestingly, excessive support from
family had a negative impact on diabetes self-care (Wen et al., 2004; Mayberry & Osborn,
2012). Well-informed families who did not participate in healthy behaviors themselves,
often sabotaged the diabetic patient’s self-care (Mayberry & Osborn, 2012). In addition,
Mayberry and Osborn (2012) tested the concept of “miscarried help” (Fales, Essner, Harris,
& Palermo, 2014). “Miscarried help” refers to family members taking over all care tasks,
which ultimately may lead to uncontrolled diabetes (Nelson, McFarland & Reiber, 2007;
Sharifirad et al., 2013). It is important that providers discuss with family members the effects
of supportive and non-supportive behaviors on the patient’s self-care and health outcomes
related to type 2 diabetes (Mayberry & Osborn, 2012).
One model for understanding diabetes and its management uses an approach of three
stages. The initial diagnosis state usually lasts one month, but in some cases may be extended
if the patient remains in a denial state. The patient also is vulnerable at this stage for a 30-day
readmission. The next state is the diabetes maintenance phase which involves performing
daily blood sugar testing, preparing healthy meals, taking medication as prescribed, and
engaging in daily exercise to maintain a healthy weight to prevent further complications and
30-day readmission (Stellefson, Dipnarine, & Stopka, 2013). Also follow-up appointments to
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evaluate the effectiveness of treatment and decisions regarding insulin type, oral medication
and dosage (Stellefson et al., 2013). This phase can interfere with school or work and
requires planning and organizational skills. Follow-up appointments and phone calls improve
patient satisfaction and decrease 30-day readmissions in this phase (Stellefson et al., 2013).
The third and long-term state, starts at about five-year post diagnosis. In this stage
complications often arise requiring patients continue follow-up visits to the primary health
care provider for weight and medication management every three months, as well as eye
examinations, and podiatrist appointments yearly. To achieve the desired health-withinillness state, it is necessary that the patient achieve overall physiological and psychosocial
adaptation to diabetes (Whittemore & Roy, 2002).
Conceptual Model
Reviewing the past 15 years literature, with the greatest focus on the past ten years in regard
to diabetes type 2 and 30-day readmissions, 30-day readmissions and race/ethnicity in type 2
diabetics, and finally 30-day readmission among Hispanics with diabetes type 2 formed the
foundation of this study. Researchers such as Jiang et al. (2003), Dugan (2012), Feignbaume
et al., 2012, Rubin et al., (2014, 2015, 2016, 2017, 2018), and Enomoto et al. (2017 )
mentioned several correlates to 30-day readmission among patients with diabetes, yet they
pointed to the gap for future studies, that is narrowing studies to more specific groups and
ethnicities in a geographic location to increase sensitivity and reliability of the predictive
model related to 30-day readmission, such as Hispanic adults with diabetes. If a more
specific predictive model can be developed, it could be applied to a similar population to
implement future cost-effective quality improvement measures like having diabetes team and
diabetes nurse practitioner in the hospital for patients with diabetes. Therefore, the
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conceptual framework for this study will attempt to identify and measure three aspects
related to hospitalized Hispanic patients with type 2 diabetes related to: (1) social
determinants of health; (2) personal and clinical factors; (3) healthcare and provider factors
and their association, separately and in relation to each other and to 30-day readmissions.
(See Figure 1)

Figure 1: Illustration of conceptual model for 30-day readmission among Hispanic with type
diabetes
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Summary
This chapter began with the review of literature that explored general factors that may
contribute to 30-day readmissions among Hispanics with type 2 diabetes. This review of
diabetes mellitus literature was organized into a conceptual framework: e.g., social
determinants of health, personal/clinical factors, nurses, diabetes nurse practitioner, and
hospitals as determinants of care. Most studies have attempted to narrow the causes related to
hospital 30-day readmission among high risk groups such as patient with diabetes. Interest in
these studies has grown for two main reasons: (1) implementing transitional care
interventions in an effort to reduce 30-day readmissions among chronically ill adults such as
those with type 2 diabetes; and (2) to decrease costs associated with 30-day readmissions in
patients with type 2 diabetes (Jack et al., 2009; Coleman, Parry, Chalmers & Min, 2006;
Walker, Gebregziabher, Martin-Harris & Egede, 2014).
Assessment of 30-day readmissions among Hispanics with type 2 diabetes could help
target the delivery of cost-effective quality improvement interventions to patients at the
greatest risk. A gap exists between creating a standardized discharge intervention with a
complete discharge and education plan, and follow-up reinforcement specific to adult
Hispanics with type 2 diabetes.
Previous studies have studied a small, select number of factors related to 30-day
readmissions. Most have conducted their work in hospitals with very limited numbers of
minority or ethnic patients, especially Hispanic patient with diabetes.
The purpose of this study is to provide clinically applicable stratification of 30-day
readmission risk among Hispanics with type 2 diabetes, with the goal of providing
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foundational information for efficacious discharge plans and interventions designed by team
members together long before hospital discharge.
This study will consider all factors that the literature has presented as potential
significant variables related to 30-day readmission among adult Hispanics with type 2
diabetes. Moreover, the study will be conducted in a setting with a preponderence of
Hispanic diabetic patients.
Findings can be used to target the delivery of precious, resource-intensive, costeffective, timely nursing, diabetes nurse practitioner, and physician interventions for adult
Hispanic patients hospitalized for diabetes. Findings from this study will provide clinically
relevant stratification of 30-day hospital readmission risks among a large sample Hispanic
adults with type 2 diabetes.
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Chapter 3
Research Methodology
Introduction
Around the globe, all healthcare systems seek to improve quality and costs constraint
therefore there currently has increased attention on 30-day readmission rates. It is projected
that Hispanic-Americans will experience the largest increase in diabetes diagnoses than any
segment of the U.S. population (Aponte and Nokes, 2017). It follows that Hispanics then
may also account for a significant proportion of 30-day readmission rates. As previously
identified, little is known about factors related to 30-day readmission rates among Hispanics
with type 2 diabetes. Knowing those factors may lead to more appropriate and targeted
interventions aimed at this particular high-risk group, potentially resulting in cost savings to
hospitals and decreased pain and stress for patients.
Purpose
The purpose of this retrospective case control study was to identify factors predictive
like increasing or decreasing factors of 30-day readmission among Hispanics with type 2
diabetes by comparing the two groups.
Specific Aims
Specific Aim 1: Measure the incidence of 30-day readmission among Hispanic adults with
type 2 diabetes in a community hospital.
Specific Aim 2: Identified factors associated with 30-day readmission among Hispanics with
type 2 diabetes.
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Specific Aim 3: Compare the ability of two different models to predict 30-day readmissions
among Hispanic with type 2 diabetes:
•

Model 1: LACE score index

•

Model 2: Model developed from the study data which includes novel variables added into
the LACE index.
Research Design
This retrospective case control study explored novel variables (variables that have not

been used in any literature reviewed studies) to predict the factors related to 30-day
readmission among Hispanic adults with type 2 diabetes. The potential study population were
all Hispanic adults with type 2 diabetes admitted to a community hospital from beginning of
2015, through 2017 meeting study inclusion and exclusion criteria. Cases were individuals
who were readmitted within 30 days of hospital discharge and controls were those without an
early readmission. The use of a case-control design was the most efficient study design to
identify adequate numbers for predictive modeling and yet limiting the amount of time
needed in abstracting the study variables from the electronic medical record (EMR)
electronic financial records (EFR), and Cerner chart review (Table 1).
Setting
This study used data from a 243 licensed bed community hospital in Southern
California with medical and surgical beds that consistently treats a large number of
Hispanics. The hospital serves the south region of San Diego County. According to the
Community Health Need Assessment (CHNA) 2013 survey for this geographic region, over
45% of adults have a diabetes diagnosis and over 60% of diabetic patient self-report as
Hispanic.
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Study Population
The study population included self-identified Hispanic type 2 diabetics admitted to
the selected community hospital between early 2015 to end of 2017. During this time period,
there were nearly 8,000 Hispanic adults with type 2 diabetes admitted to the study hospital
and approximately 15% experienced a 30-day readmission. Subjects eligible for this study
will meet the following criteria:
Inclusion criteria:
• Admission between 2015 and 2017 with a diagnosis of type 2 diabetes, A diagnosis of
diabetes as a secondary or primary diagnosis using the international Statistical
Classification of Diseases and Related Health Problems (ICD-10) discharge diagnosis of
E11.00, E11.65 (regardless of insulin use prior to hospital stay, new to insulin and oral
anti-diabetic medication) was obtained based on descriptions by diagnosis-related group
(DRG).
•

Hispanic race/ethnicity- Self-identification obtained from electronic health record.

•

Discharged from the hospital to home with either self-care or home health during the
years 2015-2017.

Exclusion criteria:
•

Pregnant patients

•

Patients younger than 18 years of age

•

Patients who died during the primary hospitalization.

•

Patients who were transferred to another hospital, hospice/palliative care or long-term
acute care and nursing home facilities.

•

Patients leaving against medical advice.
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Variables
Data variables for this study was obtained from three sources: 1) electronic medical
record (EMR), 2) electronic financial records (EFR), and 3) Cerner chart review (Table 1).
LACE Index Score
The LACE index identifies patients who are at risk for readmission or death within
30-day of discharge using four measures: Length of hospital stay; Acuity of admission;
Comorbidity Index per LACE scale; Emergency department use within six months of
admission. The LACE index was developed and validated on over 4800 patients from 11
hospitals in cities in Ontario, Canada. Van Walraven and colleagues (2010) considered 48
variables for their predictive model with four meeting their model specifications. These were
length of stay (“L;” odds ratio [OR] 1.47, 95% CI 1.25 to1.73) acuity of the admission (“A;”
OR 1.84, 95% CI 1.29 to 2.63), comorbidity (“C;” [OR 1.21, 95% CI 1.10 to1.33]), and
emergency department use (“E;” OR 1.56, 95% CI 1.27 to 1.92). The model had moderate
discrimination (C statistic 0.7025; 95% CI 0.6755–0.7295) and was well calibrated by
Hosmer-Lemshow test. The model was externally validated using all 1 million admissions
from Ontario. LACE scores range from 0 to 19. Risk of death or urgent readmission within
30 days based on the LACE score ranged from 25 for those with a 0 score to 44% for those
with a score of 19.The LACE model had moderately good predictive value, c-statistics for
training set was 0.711 (95% CI 0.674, 0.749) and for the validation set was 0.694 (95% CI
0.655, 0.732) with a good-fit assessed by the Hosmer-Lemeshow statistic (11.5, p = 0.18).
Their study found that one-point increase in LACE index score increased odds of 30-day
readmission by 18% [OR 1.18, 95% CI 1.14 to1.21] (van Walraven, et. al., 2010). Since this
study, several studies have used the LACE index to predict hospital readmission in both
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general patients and in specific populations of patient, e.g. those with COPD. In addition,
there are internet tools readily available for calculating LACE scores.
In a recent study, Damery and Combes (2017) examined whether the LACE index
score is sensitive to predict 30-day readmission or if the addition of other clinical and
sociodemographic variables would improve predictive ability of the LACE score in a British
population. They used a large data of 92,000 patients from England for the years 2013
through 2014. The British study confirmed moderate discrimination found in the original
LACE study with an area under the curve (AUC) of 0.806 (95% CI 0.801 to 0.812. A cut-off
of 11 points was most predictive of readmission but only 25% of all those readmitted had a
score of 11 or higher. However, they found use of only two variables: number of emergency
room visits in the past six months and number of hospital admissions in the prior one year
had better prediction than the LACE model [AUC=0.815; 95% CI 0.810 to 0.819] (Damery
& Combes, 2017). This was a large study with a range of co-morbidities. It obtained similar
statistics to the prior LACE study confirming the reproducibility of results but indicating that
fewer variables or even good clinical judgement may be as good at predicting 30-day hospital
readmission. (Damery& Combes, 2017).
The LACE Index is calculated using the following variables (see Appendix A for scoring
criteria):
•

Length of hospital stay: Length of stay score that is calculated based on the how many
days patient was in the hospital starts from one to seven that indicates length of stay over
14 days (L=1-7).
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•

Acuity of admission: The score for acuity of admission is calculated from if patient was
admitted to the hospital via emergency room: Then A score is three, otherwise it is zero
(A=0 or 3).

•

Comorbidities: The C score is the number of all comorbidities that is named in the next
paragraph. If patient has more than four comorbidities, he or she will receive five for box
C.

LACE comorbidities are previous myocardial infarction*, peripheral vascular

disease*, cerebrovascular disease*, congestive heart failure*, diabetes without
complication*, diabetes with end organ damage*, chronic pulmonary disease*, mild liver
or renal disease*, any tumor* [including lymphoma or leukemia], dementia*, connective
tissue disease*, AIDS*, Moderate or severe liver* or renal disease*, metastatic solids
tumor* (*LACE comorbidities are not duplicated in study comorbidities)
•

Emergency department visits in the prior six months: This is number of visits to the
emergency room in the past six months including this admission if patient is in the hospital
at the time of study. This number will not exceed four.

Then added numbers from box “L” to box “A” to box “C” and box “E” calculate a “LACE”
score. This LACE score >10 is indicative of high risk for a 30-day readmission based on
previous researchers’ study. (Robinson & Hudali, 2017).
Study variables not included in LACE Index
The literature review suggested measuring other variables besides LACE index score
ones to increase specificity and validity. Variables such as, sex and age were included in
most models but were not predictive of 30-day readmission when other variables were in
the model (Kansagara et al., 2011). Variables like clinical data, severity of the illness,
comorbidities and social-determinant of health increase predictability of 30-day readmission
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but were not measured in most studies (Kansagara et al., 2011). A few other variables, such
as specific diagnosis group codes (Demary & Combes, 2017) or demographics such as
gender (Demary & Combes, 2017), race/ethnicity (Demary & Combes, 2017) did not
increase predictability of 30-day readmission but these variables have added benefit for
increased validation based on the studied community hospital. Other variable (Kansagara et
al., 2011) but insurance has been considered in some models.
• Socio-demographic information: age, gender, language, marital status, employment
status including employed, unemployed, disability and retired, insurance including
commercial/other insurances, Medicare and Medi-Cal (poverty criteria is defined as
Medi-Cal eligibility). (Table 1).
•

Behavioral risk: Smoking or alcohol drinking,

•

Comorbidities: Myocardial infarction (MI), Cerebrovascular accident (CVA),
peripheral vascular diseases (PVD), chronic pulmonary disease (COPD), Liver disease,
dementia, connective tissue disease, diabetes with complications, cancer, renal disease
(Table 3).

•

Clinical lab values during hospitalizations specifically:
o

HgA1C measured on admission – a measure of blood glucose levels in the prior
three months; >7% is considered uncontrolled
Uncontrolled glycemia - defined as two or more consecutive days of blood glucose
recordings above 180 mg/dl or a blood glucose less than 70 mg/dl at any time
during the hospital stay (Table 2).

• Discharges status: 1) home alone, 2) home with home health
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• Consults: Patient received consult to: 1) social worker/case manager, or 2) diabetes nurse
practitioner and 3) diabetes educator (Table 4).
Identifying Study Participants
All Hispanic adults with type 2 diabetes who were admitted in 2015, 2016 and
2017 who met the inclusion and exclusion criteria were eligible for the study. Cases were
those who were readmitted within 30-days of discharge. Controls were those who were not
readmitted within 30-days. A patient was only eligible once for the study (e.g. if a subject
was identified as a case in 2015, they could not be a case or control if readmitted in 2016 in
order to maintain statistical assumptions of independence). Cases and controls were drawn
fairly equally among the three years and over the 12 months to avoid time and seasonal
effects.
Based on literature review, a sample size of 400 subjects (200 readmitted and 200 not
readmitted) would adequate to develop a predictive model using a random 200 for
developing the model and the other 200 for validating the model. (Vergouwe et al., 2005;
Peduzzi et al.,1996).
Analytic Approach
Initial descriptive statistics were done on all study variables. For continuous
variables, the distribution of the values was examined and either left the variable as a
continuous measure or categorized it by natural cut-points from the distribution.
Distributions also determined the best presentation for continuous variables as means with
standard deviation for normally distributed variables or median and interquartile range for
skewed data. Bivariate analysis between sociodemographic/behavioral characteristics,
clinical characteristics, comorbidities and consult characteristics was performed.
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Multivariable logistic regression modeling in order to adjust for potential confounding
between those readmitted and those not readmitted. Any variables showing association with
30-day readmission were considered for the multivariable regression. Variables were
retained in the model if they had a p-value < 0.05 or changed the effect estimate by 10%.
A split-sample design was used to develop and then test the study predictive model
(study model). A random selection of 49% Derivation group and validating the model within
validation group (51%) was comprised the sample for creating the study’s model for
predicting readmission (see Figure 1). Bivariate logistic regression analysis between
variables and 30-day readmission was calculated. Any variable with a p<0.10 was included
in the initial regression model. Backward stepwise regression approach was used to identify
variables which produced the best area under the curve (AUC). The area under the curve
(AUC) and calibration statistic (C-statistic) was calculated for the model with all qualified
variables and then dropping variables above p<0.05. These were compared for best fit. In
addition, the Hosmer-Lemshow test was calculated to assess model stability (Giancristofaro
and Salmaso, 2007). After the study model was defined, it was tested in the other half of the
study sample, the validation group. The same AUC, C-statistics, and Hosmer-Lemshow test
was calculated. These statistics were compared between the derivation and validation
samples. Sensitivity, specificity, and positive predictive values were calculated for the
models.
The LACE scoring was applied to the entire sample and the previously described
statistics for the studied model was calculated. A comparison of the statistics between the
two was made to assesse predictive ability between the two models.
Protection of human subjects
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The study methodology received approval from both the institutional review boards
(IRB) for the University of San Diego and the participating hospital.
An initial dataset identifying qualifying participants with a type 2 diabetes diagnosis
and meeting the study inclusion and exclusion criteria was made by hospital data system
personnel. This dataset with patient identifiers remained on the premises of the hospital. A
copy of this dataset was on the researcher’s computer which was passworded but free of
specific identifiers, such as the complete medical record number. This de-identified dataset
was used to input abstracted data only available in the patient’s medical record on the Cerner
server. The principal investigator’s computer was kept in a locked office/cabinet when not in
use by the researcher. By securing the data in safe place and de-identifying the data, this
study posed minimal risk to the potential subject’s health and welfare. Precautions was taken
to protect patient privacy in accordance with the Health Insurance Portability and
Accountability Act (HIPPA). Access to patient identifiers was limited to the primary
investigator (working for the same hospital).
Study timeline
The initial data file was received by the second week of January, 2019 and took over
5 months to identify the study sample of single individuals and, randomly choose a single
admission among those with multiple admissions and to obtain information from the Cerner
health record. The completion of data collection and data cleaning was done by end of May,
2019. The preliminary analyses were begun in June, 2019.
Ethical issues
No ethical issues were encountered during the conduct of this study.
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CHAPTER 4
RESULTS
The purpose of this retrospective case-control study was to identify predictive factors
related to 30-day readmission among Hispanic adults with type 2 diabetes. The population of
Hispanic adults was selected because 69% of the patients served by the community hospital
speak Spanish. Further, related data from this hospital indicated over 62% of patients with a
primary or secondary diagnosis of diabetes admitted in 2017 self-defined as Hispanic.
Description of the Sample
From 2015 to 2017, the years of this study, the rate of 30-day readmission among all
patients with diabetes admitted (14.7%-22.2%) to the study hospital ranged from 11.8% in
2015 to 9.4% in 2017.
Initially, there were 7,920 patients hospitalized with a primary or secondary diagnosis
of type 2 diabetes (as defined by ICD-10) who self-defined as Hispanic from early 2015 to
the end of 2017. After excluding those that did not meet study criteria due to death during
hospitalization, were discharged to nursing home, or left against medical advice, there were
5,985 patients meeting study criteria. However, 15% of Hispanics with diabetes type 2 were
admitted multiple times during the study period. After randomly choosing only one
admission for patients admitted multiple times, the final study sample was 3,865.
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Figure 1: Illustration of sample selection procedure.
Research Aim 1
Research Aim 1 was to measure the incidence of 30-day readmission among Hispanic
adults with type 2 diabetes in a community hospital by sociodemographic, behavioral
characteristics and clinical factors.
Sociodemographic and Behavioral Characteristics
The overall readmission rate of the study sample was 9.5%. The mean age of the
sample was 65 years (SD=14.6) (Table 1). Compared to the 69% being Spanish speaking
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only subjects, the 31% who spoke English-only had a statistically non-significant 19%
increased odds of 30-day readmission (OR =1.19; 95% CI, 0.95-1.50). Unsurprisingly, over
half the sample was insured by Medicare and one-third by Medi-Cal. Nearly half were
retired with another 20% disabled and only 15% employed.
Differences in sociodemographic, clinical data, specific comorbidities, consults, and
hospital discharge disposition were compared by 30-day readmission status. The bivariate
analysis of sociodemographic characteristics showed gender, age, language spoken, and
marital status were not statistically significant associated with 30-day readmission (Table 1).
Those with Medi-Cal and Medicare had a 50 to 59% increased odds of early readmission,
respectively (Table 1). Compared to those who were employed, the retired and unemployed
had a 65-69% increased odds and those who were disabled had nearly 2.5 times the odds of
early readmission (OR =2.49; 95% CI, 1.60-3.90). Male gender and unmarried status
increased the odds of 30-day readmission by 12-22% (OR =1.12; 95% CI, 0.90-1.39 and
1.22; 95% CI, 0.98-1.51 respectively) Smoking status was also marginally associated with
30-day readmission (OR =1.39; 95% CI, 0.99-1.94) (see Table 1).
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Table 1: Bivariate association between behavioral and sociodemographic characteristics
by 30-day readmission status
Variable

Total Sample
(N=3865)
n (%)

Not
Readmitted
(n = 3496)
n (%)

Readmitted

Odds ratio
(95% CI)

(n=369)
N (%)

Age Mean (SD)

65 (14.61)

Gender
Male
Female

3865
1872 (48.4)
1993 (51.6)

3496(90.5)
1684 (48.2)
1812 (51.8)

369(9.5)
188 (50.9)
181 (49.1)

1.12 (0.90-1.39)
Reference

Language
Spanish
English

2646 (68.6)
1212 (31.4)

2406 (69.0)
1083 (31.0)

240 (65.0)
129 (35.0)

Reference
1.19 (0.95-1.50)

Marital Status
Unmarried
Married

1985 (51.4)
1875(48.6)

1779(51)
1712(49.0)

206(55.8)
163(44.2)

1.22 (0.98-1.51)
Reference

Medi-Cal
Medicare
Other insurance

1340(34.7)
2043(52.9)
482(12.5)

1211(34.6)
1835(52.5)
450(12.9)

129(35.0)
208(56.4)
32(8.7)

1.50(1.01-2.24)
1.59(1.08-2.35)
Reference

Employment
Employed
Unemployed
Retired
Disability

458(14.6)
526(16.7)
1539(48.9)
623(19.8)

430(15.2)
474(16.7)
1390(49.1)
536(18.9)

28(8.9)
52(16.5)
149(47.2)
87(27.5)

Reference
1.69(1.05-2.72)
1.65(1.08-2.50)
2.49(1.60-3.90)

Smoker
Non-Smoker

363(9.4)
3502(90.6)

318(9.1)
3178(90.9)

45(12.2)
324(87.8)

1.39 (0.99-1.94)
Reference

Insurance

LACE Criteria
Length of stay (LOS) was a statistically significant predictor of 30-day readmission.
The mean LOS for the sample was 4 days (SD = 3.7) with length of stay 4.11(3.64) for those
not readmitted and 5.63(5.43) for the readmitted group (P<0.001) (Table 2). The LOS as a
categorical variable showed 2.3% staying 14 or more days, 13% staying 7-13 days, 28%
staying 4-6 days and 57% staying 3 or fewer days. Patients staying 14 or more days had
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nearly 4 times higher odds of 30-day readmission (OR= 3.72; 95% CI, 2.22-6.21) compared
to those who stayed 3 days or fewer. Patient staying 7-13 days had 75% higher odds of 30day readmission (OR= 1.75; 95% CI, 1.29-2.39), and those staying 4-6 days had 45% higher
odds of readmission (OR=1.45, 95% CI, 1.13-1.89) compared to those stayed 3 days or fewer
(see Table 2).
Acuity of admission. The second component of LACE, acuity of admission, was
rated high if admission was through the emergency department and low if admission was
directly from a primary care office. In this sample, the vast majority of admissions were
through the emergency department, 91.5%. Therefore, this component of the LACE index
was not statistically associated with 30-day readmission (see Table 2).
Comorbidity. The third component of LACE is comorbidity. The LACE comorbidity
index (CI) is calculated based on several components and points can range from 0 to 6 (See
Chapter 3). All subjects in this study earned at least 1 point since they all had diabetes. Less
than one-fourth had one other comorbidity. No subjects met the criteria to earn 6 points. The
odds of being readmitted increased with an increasing number of comorbid conditions
although this was not statistically significant until a subject earned 4 or 5 points. Those with
5 points had an odds ratio for readmission of 1.75 (95% CI,1.26-2.43) (See Table2).
Emergency department visits. The last component of the LACE index score is the
number of emergency department (ED) visits in the past six months exclusive of the ED visit
leading to the current admission. Zero to three visits were scored as the actual number of
associated ED visits, but four or more visits were all scored as four. Not much variance was
detected in the data. This was likely due to a large portion of study patients receiving care
through the ED because they have no primary care physicians and because ED visits require
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no copayment and feature same-day patient care. The odds of 30-day readmission increased
when using the ED for their treatment. Out of whole sample, 2% of diabetics used the ED
more than four times prior to their admission which increased their readmission odds 12
times compared to the one who did not have ED visit prior to their admission. One-fourth of
patient with one ED visit before their admission had 10 times higher odds of 30-day
readmission (see Table 2).
Other clinical characteristics
A HgA1C, a measure of blood glucose levels in the prior three months, more than 7%
is considered uncontrolled diabetes. The mean HgA1C was 7.54% (SD = 1.90) and the
means by readmission status were not different (see Table 2). HgA1C was also analyzed as a
categorical variable divided into three groups: 1) less than 7%, 2) 7-9% and 3) over 9%. As
categorical data, 19% of all diabetic admissions had a HgA1C above 9% which was
marginally associated with a higher rate of 30-day readmission (OR=1.29; 95% CI, 0.951.76). One-third of the sample had an intermediate level of HgA1C (7-9%) which was not
associated with readmission (OR=1.01; 95% CI, 0.77-1.32) (see Table 2).
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Table 2: Bivariate logistic regression Clinical characteristics of the study sample overall
and by 30-Day readmission status
Variable

LOS mean (SD)
LOS > 14 days
LOS 7-13 days
LOS 4 -6 days
LOS < 3 days

Total
Sample
N=3865
n (%)

Not
Readmitted
n= 3496
n (%)

Readmitted

Odds Ratio
(95% CI)

n =369
n (%)

4 (3.7)
89 (2.3)
495 (12.8)
1079 (27.9)
2202 (57.0)

4.11(3.64)
68(1.9)
432(12.4%)
963(27.5)
2033(58.2)

5.63(5.43)
21(5.7)
63(17.1)
116(31.4)
169(45.8)

3.72 (2.22-6.21)
1.75 (1.29-2.39)
1.45 (1.13-1.86)
Reference

A-Acuity
Low Acuity
High Acuity

328 (8.6)
3495 (91.4)

3496(90.5
297(8.6)
3160(91.4)

369(9.5)
31(8.5)
335(91.5)

Reference
1.02 (0.69-1.50)

C-Comorbidity
Diabetes type 2
DM+1 cm
DM+2 cm
DM+3 cm
DM+>4 (severe)

915 (23.9)
929 (24.3)
727 (19.0)
583 (15.2)
669 (17.5)

842 (24.4)
855 (24.7)
661 (19.1)
518 (15.0)
581 (16.8)

73(19.9)
74 (20.2)
66 (18.0)
65 (17.8)
88 (24.0)

Reference
1.0 (0.71-1.40)
1.15 (0.81-1.63)
1.45 (1.02-2.06)
1.75 (1.26-2.43)

ED visit past 6 m.
No visits
3569 (92.3)
1 visit
213 (5.5)
2 visits
44 (1.1)
3 visits.
24 (0.6)
4 or more visits
15 (0.4)

3322 (95)
124 (3.5)
28 (0.8)
14 (0.4)
8 (0.2)

247 (66.9)
89 (24.1)
16 (4.3)
10 (2.7)
7 (1.9)

Reference
10.0 (7.14-13.05)
7.69 (4.10-14.40)
9.61 (4.22-21.85)
11.80 (4.23-32.72)

HgA1C (Mean)
>9.1%
7-9%
<7%

7.53(1.89)
500 (18.2)
937 (34.0)
1317 (47.8)

7.65(2.04)
67 (22.2)
98 (32.5)
137(45.4)

1.29 (0 .95-1.76)
1.01 (0.77-1.32)
Reference

7.54 (1.9)
567 (18.6)
1035 (33.9)
1454 (47.6)

Comorbidities
Comorbidities were identified based on the index admission ICD10-CM codes.
Adults with diabetes are more at risk for cardiovascular diseases. The data showed
congestive heart failure (CHF) increased the odds of 30-day readmission 36% (OR=1.36;
95% CI, 1.08-1.71) compared to those without CHF. In addition to type 2 diabetes, the
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presence of other added comorbidities that increased the odds of 30-day readmission in the
bivariate analysis were liver disease 55% (OR=1.55; 95% CI, 1.10-2.18) connective tissue
disease 95% (OR=1.95; 95% CI, 1.01-3.77), and renal disease 24% (OR=1.24; 95% CI, 1.01.53) (see Table 3).
Comorbidities like cerebrovascular disease (CVA) and myocardial infarction (MI) did
not increase 30-day readmission in the bivariate analysis. No patients were coded with moderate
to severe liver disease nor HIV/AIDS. Presence of a discharge code for diabetes complications,
decreased the odds of readmission by 25%.
Table 3: Bivariate logistic regression Clinical DX ICD-10 Characteristics of the Study
Sample Overall and by 30-Day Readmission Status
Variable

Total Sample
Not
Readmitted
N=3865
Readmitted
n (%)
n = 3496
n=369
n (%)
n (%)

Odds ratio
(95% CI)

Comorbidities
MI

294 (7.7)

265 (7.7)

29 (7.9)

1.04 (0.70-1.55)

CVA

347 (9.1)

316 (9.1)

31 (8.5)

0.92 (0.63-1.35)

PVD

568 (14.9)

507 (14.7)

61 (16.7)

1.16 (0.87-1.56)

CHF

1088 (28.5)

962 (27.8)

126 (34.4)

1.36 (1.08-1.71)

COPD

774 (19.2)

667 (19.0)

77 (21.0)

1.12 (0.86-1.46)

Liver disease

317 (8.3)

274 (7.9)

43 (11.7)

1.55 (1.10-2.18)

Dementia

178 (4.7)

156 (4.5)

22 (6.0)

1.35 (0.85-2.14)

Connective tissue

65 (1.7)

54 (1.6)

11 (3.0)

1.95 (1.01-3.77)

1329 (34.8)

1223 (35.4)

106 (29.0)

0.75 (0.59-0.94)

261 (6.8)

233 (6.7)

28 (7.6)

1.15 (0.77-1.73)

1538 (39.8)

1374 (39.4)

164 (44.4)

1.24 (1.0-1.53)

Disease
Diabetes with
Complications
Cancer
Renal Disease
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Consult characteristics
Diabetic patients frequently had consults to be seen by case managers, diabetes
educators, and diabetic nurse practitioners. For these three types of consults, the most
frequent was with a diabetes nurse practitioner who saw slightly more than 70% of patients.
The type of consult that occurred was not associated with 30-day readmission.
However, the presence of a consult for a home health aide at discharge was
associated with 30-day readmission. Nearly 23% of those readmitted were discharged with a
home health aide consult compared to only 15% who were not experience readmission.
Almost one fourth of subjects who were discharged to home used home health services
(23%) versus three-fourths going home with self-care (77%). Discharge disposition with
home health aide increased the readmissions odds by 68% compared to those who were
discharged home on self-care (OR=1.68, 95% CI, 1.29-2.20) (see table 4).
Table 4: Bivariate logistic regression Consults characteristics of the study sample
overall and by 30-Day readmission status
Variable

Total Sample

Case manager

N=3865
n (%)
1507 (39.0)

Not
Readmitted
n = 3496
n (%)
1360 (38.9)

Readmitted
n= 369
n (%)
147 (30.8)

1.04 (0.85-1.26)

Diabetes NP

2721 (70.4)

2457 (70.3)

264 (71.5)

1.06 (0.85-1.31)

Diabetes Educator

1076 (27.8)

963 (27.6)

111 (30.1)

1.13 (0.90-1.38)

Home w. HH

622 (16.1)

536 (15.3)

86 (23.3)

1.68 (1.29-2.20)

Home self-C.

3243 (83.9)

2960 (84.7)

283 (76.7)

Research Aim 2
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Odds ratio
(95% CI)

Reference
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Research Aim 2 was to identify independent factors associated with 30-day
readmission among Hispanic adults with type 2 diabetes accounting for potential covariates.
The presence of any difference in baseline characteristics between the cohort who
experienced 30-day readmission and those not readmitted was analyzed by multivariable
logistic regression using any variable in Tables 1-4 with a p < 0.1 Only ten independent
variables met these criteria for the multivariate modeling (see Table 5).
This multivariable model contained 10 variables. The full model was statistically
significant with omnibus chi square (X2) 64.82, 10 degree of freedom, P<.001. The HosmerLemeshow goodness of fit chi square (X2) 7.58 with P=0.48, indicating the model was a
good fit for the data (Hosmer & Lemeshow, 2000). Employment status variables had the
strongest predictive values in the model with disability having the highest odds (OR=2.43;
95% CI, 1.51-3.90) followed by unemployed and retirement status. Discharge with a home
health care consult increased the odds of readmission 59% (OR=1.59; 95% CI 1.19-2.13).
After accounting for covariates, only liver disease remained a small risk factor for
readmission (OR= 1.60; CI 95%, 1.10-2.36) although a code of diabetes complications
marginally decreased the odds of readmission (OR=0.77; 95% CIO 0.59-1.01).
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Table 5: Multivariable Logistic Regression Results of the final study variable by 30-Day
readmission
Variables
B
S.E.
Wald
df
p
OR (95% CI)
Constant

-3.115

HH VS. Self-Care

0.464

0.148

9.850

1

0.002

1.59 (1.19-2.13)

Unemployed

0.534

0.256

4.361

1

0.037

1.71 (1.03-2.82)

Disability

0.887

0.242

13.426

1

0.001

2.43 (1.51-3.90)

Retired

0.518

0.233

4.949

1

0.026

1.68 (1.06-2.65)

CTD

- 0.556

0.379

2.147

1

0.143

1.74 (0.83-3.66)

CHF

0.193

0.131

2.176

1

0.140

1.21 (0.94-1.57)

DM Complications

-0.258

0.136

3.605

1

0.058

0.77 (.59-1.01)

Liver Disease

0.472

0.196

5.767

1

0.016

1.60 (1.10-2.36)

Index Length of Stay

0.045

0.013

11.682

1

0.001

1.05 (1.02-1.07)

Smoking

0.339

0.186

3.331

1

0.068

1.40 (0.98-2.02)

CTD = Connective tissue disease; CHF = congestive heart failure; DM= diabetes mellitus

Research Aim 3
Research Aim 3 was to compare the ability of a model developed from the study
variables, the Hispanic Diabetic Study Model, to a LACE model to predict 30-day
readmission among Hispanic adults with type 2 diabetes.
The study sample was randomly selected into two groups: derivation and validation.
The derivation group size was n=1896 (49%) and the validation group size was n=1969
46

47

(51%). Both groups had the similar demographic and clinical characteristics. The derivation
group was used to develop a predictive model for 30-day readmission and then the stability
of the model was tested in the validation group. The number of missing cased for the
Hispanic Diabetic Model is 743(19%) and with LACE model 42(1.1%).
Developing the predictive models
In order to test the predictive ability, the derivation group was examined comparing
the Hispanic Diabetic Study variables, the LACE model, the LACE index score as a
categorical variable and finally the Hispanic Diabetic Study plus a key identified variable
from LACE. The betas from the derivation group models were applied to the validation
dataset. To establish the stability of the estimates.
The Hispanic Diabetic Study Model: This model started with the 10 variables from
the model derived in Research Aim #2. Using backward stepwise regression, the least
predictive variables were eliminated to obtain the most predictive model. (See Table 6 for
relative magnitude of the variables)
LACE Models
The LACE models used the published variables and definitions from the literature.
Since all subjects had diabetes, comorbidities scoring was modified with 1 meaning one
comorbidity in addition to diabetes, similarly for 2 through 4. The ‘LACE Model’ grouped
length of stay as three groups with a stay of 3 days or less as the reference group. In this
model, all other LACE criteria were as published.
Results
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The LACE index score
In this study the mean LACE index score was 7.74 (SD = 2.61) with a range from 0
to 16. For the total sample, for every point increase in the LACE score, the odds of
readmission was 1.09 (95% CI. 1.03-1.15). Using the published LACE cut-score of 9, 8.6%
of those with a score of 9 or less were readmitted within 30 days compared to 14.7% with
those with scores greater than 9. The odds for readmission for a score above 9 was 1.83 (95%
CI, 1.41, 2.37). Using the cut-off score produced the poorest AUC (0.56) and therefore, no
further analysis using the LACE cut-off was pursued.
Predictive Models
The relative magnitude of the predictive variables is presented in Table 6. Emergency
department visits in the prior 6 months had the largest odds ratios followed by disability
status.
The Hispanic Diabetic Study Model final multivariable predictive model included
five variables employment status (unemployed, retired, or disabled), smoking, admission
length of stay, consult with home health aide and diabetes complications (see Table 7). This
model accurately identified 90% of all the cases with a sensitivity of 0% and specificity of
99% with overall accuracy (the true positives + true negatives/ sample size) of 73% (Zhu,
Zeng & Wang, 2010). The Hispanic Diabetic model predicted cases compared to the actual
30-day readmission cases was able to predict 71.6% correctly and 28.5% incorrectly among
derivation group and to predict 73.6% correctly and 26.4% incorrectly among validation
group. This Hispanic Diabetic model was only moderately predictive of 30-day readmission
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with an area under the curve (AUC) of 0.06-0.63 with adequate calibration per the HosmerLemeshow goodness chi-square of X2 well above p=0.05
The LACE Model included all of the LACE variables. Emergency department visits
in the prior 6 months had the largest effect size by far (See Table 6). All eight independent
variables accurately identified 90% of all the cases with a sensitivity of 9.4% and specificity
of 99% between both groups and an overall accuracy of the model is 90%. The LACE model
was able to predict 89.6% of the cases correctly and 10.4% incorrectly among derivation
group and to predict 89.4% correctly and 10.6% incorrectly among validation group
demonstrating stability of the model. The LACE model had a better AUC than the Hispanic
Diabetic Study of 0.67-0.69 which showed stability between the two sets with adequate
calibration (See Table 8).
The Hispanic Diabetic Study model plus ED visits in the last 6 months had similar
model statistics to the LACE model. This model had a sensitivity slightly lower than the
LACE model of 5.2% but a higher specificity of 99.5% with overall accuracy of 73%. The
Hispanic Diabetic Study plus ED visits model predicted 72.4% of the cases correctly and
27.7% incorrectly among derivation group and to predict 73.5% correctly and 26.5%
incorrectly among validation group demonstrating stability of the model and consistency of
the data with the model. This model had similar AUC to LACE (See Table 8). However, the
positive predictive value (i.e., of the people the model identified as being at risk for
readmission, the percent who were actually were re-admitted) was 55.7% compared to 52.1%
for the LACE model. Figure 1 is a comparison of the ROC curves for all three models.
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Figure 5: Area under the Curve for three different predictive models
Purple = Hispanic Diabetes Study; Green = LACE; Blue = Hispanic Diabetes + ED visits
Table 6: Odds ratios for variables associated with 30-day readmission for Diabetes
Study Model and LACE Model using the derivation group
Variable
Home health
Unemployed
Disability
Retired
DM Complications
Index LOS
Smoking

Hispanic Diabetes
Study Model
1.65
1.39
2.29
1.69
0.68
1.03
1.55

Lace Models
Length of stay
LOS > 14 days
LOS 7-13 days
LOS 4 -6 days
Acuity-high
Comorbidity
DM+1 cm
DM+2 cm
DM+3 cm
DM+>4 (severe)
ED visit past 6 m.
1 visit
50

1.042
1.26
1.34
1.75
0.61
0.76
1.10
1.38
1.31
6.04
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2 visits
3 visits.
4 or more visits

10.42
14.59
3.21

Table 7: Predictive model statistics for the three models from the Derivation Set
Hispanic
Diabetes
Study Model

LACE model

Hispanic Diabetic
Study + ED

Constant
-2.883
-2.238
-2.882
Variables [Beta (S.E)]
Home health*
0.503 (0.210)
0.476 (0.220)
Unemployed
0.328 (0.365)
0.152 (0.376)
Disability *
0.827 (0.336)
0.355 (0.324)
Retired
0.526 (0.316)
0.526 (0.316)
DM
-0.390 (0.197)
-0.528 (0.207)
Complication*^
Index LOS
0.033 (0.023)
0.018 (0.024)
Smoking
0.436 (0.265)
0.312 (0.279)
Length of stay
LOS > 14 days
0.237 (0.186)
LOS 7-13 days
0.295 (0.240)
LOS 4 -6 days
0.561 (0.433)
Acuity-high
-0.492 (0.257)
Comorbidity
DM+1 cm
-0.275 (0.261)
DM+2 cm
0.091 (0.256)
DM+3 cm
0.320 (0.257)
DM+>4 (severe)
0.268 (0.248)
ED visit past 6months
1 visit Ϯ
1.798 (0.244)
2.073 (0.270)
Ϯ
2 visits
2.344 (0.476)
2.245 (0.566)
Ϯ
3 visits
2.680 (0.691)
2.323 (0.790)
4 or more visits Ϯ
1.165 (1.133)
___
*
= p<0.05; ^ = only applies to Hispanic Diabetic model; Ϯ = p < 0.001
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Table 8: Area under the Curve and Calibration for predicting 30-day readmission for
three predictive models in the derivation and validation data sets
Set

Hispanic Diabetic
Study:
Derivation
Validation
LACE model:
Derivation
Validation
Hispanic Diabetic
Study + ED visits:
Derivation
Validation

Area under the Curve
(95% CI)

Calibration
(HosmerLemeshow)

0.60 (0.58-0.67)
0.63 (0.60-0.70)

0.83
0.68

0.69 (0.61-0.70)
0.67 (0.70-0.79)

0.80
0.91

0.67 (0.65 – 0.75)
0.69 (0.73-0.81)

0.94
0.79

Summary
The 30-day readmission rate for Hispanic diabetics in this study was 9.5%. Few of
the social-demographic variables tested in the Hispanic Diabetic Study’s conceptual
framework were predictive of readmission except employment status. A history of smoking
was also an important predictor along with longer length of stay. Interestingly, having a code
for a diabetes complication decreased the risk for readmission.
Among the predictive models, the best predictive model included the study variables
plus the number of ED visits in the prior 6 months. However, even though this was the best
model its AUC was only around 0.67. It had excellent specificity but poor sensitivity 5%
although the positive predictive value was 57.4%.

52

53

CHAPTER 5
DISCUSSION
The purpose of this retrospective study was to identify predictive factors related to
30-day readmissions among Hispanic adults with type 2 diabetes admitted to a community
hospital in Southern California and to evaluate whether there can be a predictive model to
identify those most at risk for a 30-day readmission. The study hospital primarily serves
Hispanic adults of lower socioeconomic bracket as reflected by the study data showing the
majority were insured by public insurers, Medicare (53%) and Medi-Cal (35%), with only a
minority (12.5%) covered by other insurance or commercial payers. This chapter discusses
the study findings, strengths, limitations, and implications for future clinical, education,
policy implication and nursing research.

Study findings for Aims 1 and 2
The study cohort had an overall 30-day readmission rate of 9.5% and 14.7% for the 3
years if those with multiple admissions are included. Among the independent predictors
represented in the study’s conceptual framework, only few factors were identified as
predictive of 30-day readmission. Employment status was associated with the highest odds
for readmission. Only 15% of the cohort were employed. Those who were disabled (20%)
had an adjusted 2.43 (95% CI 1.51-3.90) increased odds of readmission followed by those
who were retired (49%) with an adjusted odd of 1.68 (95% CI ;1.06-2.65). If the person was
a smoker, it marginally increased odds of readmission (adj. OR 1.40; 95% CI 0.98-2.20).
Among the healthcare and clinical factors studied, the number of visits to emergency room in
the prior 6 months was the strongest predictor ranging from an adjusted odd of 6.04 for 1
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visit to 14.56 for 3 visits. This was followed by length of stay OR=1.75 for 4-6 days or an
increase of 5% odds for every day in the hospital. Receiving a consult for a home health aide
at discharge was an important factor (adj. OR = 1.59; 95% CI 1.19-2.13). Surprisingly,
having a diabetes complications code in this study decreased the odds of 30-day readmission
(adj. OR = 0.77; 95% CI 0.59-1.01) even though HgA1C above 9% did slightly increase the
odds of 30-day readmission.
Findings that were investigated but did not appear to be independently associated
with language spoken, several co-morbidities, and consults with diabetes nurse practitioners
or diabetes educators. The majority of the cohort were designated as Spanish-speaking,
nearly 69%, and 70% of all participants were seen by a diabetes nurse practitioner.
Some results are similar to those found in other studies of 30-day hospital
readmission among those with diabetes and are not. Of note, the overall 30-day readmission
rate for the three years of 14.7% and for those in the study cohort of 9.5%, is much lower
than those of other published studies. In fact, over the three years of the study, the
readmission rate in the cohort declined from 11.8% to 9.5%. Rubin (2015) reported 30-day
readmissions were higher among patients with diabetes compared to those without (15.3%
versus 8.4% respectively, p < 0.001), and comparable findings have been reported in similar
studies (14.4–22.7% vs. 8.5–13.5%; Sonmez, Kambo, Avtanski, Lutsky, & Poretsky, 2017).
The decreasing rate of readmissions over time indicate this hospital has purposefully worked
to decrease 30-day readmissions and have been successful among Hispanics with diabetes.
Rubin and colleagues (2016) examined 30-day readmission risk factors among
diabetics. Their population was 12% Hispanic and they did not find Hispanic ethnicity
associated with readmission nor language spoken. Like this study, employment status was an
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important predictor of readmission although the odds ratio in this study are 16 to 25% higher.
Two other studies also found employment status associated with 30-day readmission in
general (Jiang et al. 2005; Feigenbaum et al. 2012).
Although clinical factors such as HgbA1C on admission and co-morbidities were
investigated only one was important in a surprising direction. Although an HgbA1C >9 was
marginally associated with readmission (OR 1.29; 95% CI 0 .95-1.76), it was not important
after accounting for covariates. Other co-morbidities that are higher risk factors for
readmission in the general population, such as CHF and COPD, were not important in this
specific population. The fact that having diabetes complication code among this study of
Type 2 diabetics decreased odds for re-admission may mean hospital care may appropriately
targeted care to these patients, and therefore, it may have been successful in preventing them
from experiencing an early readmission.
This hospital had an innovative approach to caring for diabetic patients and achieving
glycemic control through with the use of diabetes nurse practitioners. diabetes nurse
practitioners were utilized for glycemic management by providing education at bedside. Over
70% of study participants had a diabetes nurse practitioner consult which probably limited
the ability to assess any effect of these practitioners to prevent readmissions. Also, this study
was limited to those who entered the hospital already with a diagnosis for Type 2 diabetes. A
prior study showed an early primary diagnosis of diabetes during an admission helped
facilitate proper medication reconciliation for precise diabetes medication to fit patients’
levels of knowledge, and the ability to carry out self-medical management at home (Jack et
al., 2009). This study found effective use of a diabetes team was linked to decreased ED
visits for patients with type 2 diabetes-related complications. The fact that those with a
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diabetes complication code had a reduced readmission may be a proxy indicator of an
effective functioning diabetic team.
The rate of readmission among the high acuity group (admitted from ED) and low
acuity group (admitted from PCP office) was not an important factor in predicting
readmission (OR 1.02; 95% CI 0.69-1.50) since the vast majority of admissions were through
ED (91.4%) regardless of severity of condition. This is an important finding. The original
LACE predictive model was developed and tested in Canada and the United Kingdom were
admission to the hospital from the ED versus a primary care office may be a good proxy
measure of severity of illness (van Wal raven et. al., 2010; Damery & Combes 2017). The
Emergency Medical Treatment and Labor Act makes the use of emergency department much
more attractive to all immigrants regardless of their status. All patients will receive care at
ED even if they cannot afford the copay unlike in doctor’s offices, therefore, immigrants
have a disincentive to receive care at primary care offices (Ortega, Rodriguez, and Vargas
Bustamante, 2015).
Lastly, those discharged home had a higher rate of 30-day readmission. This finding
echo that of a re-admission study post-pancreatomy that found increased odds of readmission
with a home health consult although the readmitted patients were less severe than those
readmitted without such a consult (Sanford et al., 2014). The degree of severity on
readmission was not assessed in this study, so that aspect could not be evaluated. However,
the fact that those discharged with a home health consult had a higher rate of readmission
may indicate the hospital recognized these individuals had increased care needs but efforts to
provide them with extra resources and surveillance were insufficient to keep these higher risk
patients from being re-admitted. Also unknown is if the home health care consults actually
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took place prior to readmission and the timing of the receipt of needed services. These are
potential subjects of future research.
Study findings for Aim 3 – Predictive models
Finding a predictive model that could target those individuals at highest risk of early
readmission would be beneficial for both hospitals and patients and their families. However,
to date, most predictive models for hospital readmission have performed fairly poorly
(Kansagra, 2011). The LACE model was original developed and tested in Canada and
validated in the United Kingdom with very different health care and payment systems which
may threaten its validity in the U.S. health care system (van Wal raven et. al., 2010; Damery
& Combes 2017). Many U.S. hospitals are using the LACE model or the LACE index score
>9 to identify high risk readmission patients with LACE calculators readily available on the
internet. In this study, The LACE index score among Hispanics with type 2 diabetes failed to
predict 30-day readmission. One reason as already cited previously may have been the fact,
particularly in this community, the vast majority of patients are admitted through the ED and
therefore, the ‘A’ for acuity in LACE is not an important predictor. Among the LACE
variable, the number of ED visits in the prior 6 months had the highest predictive odds
between 7.61 to 11.80. Testing of the predictive ability LACE model and the Hispanic
Diabetic Study plus ED visits in the prior 6 months provided similar results although the
latter model was slightly better. The AUC for this model was only around 0.67 with a high
specificity of 99.5% and low sensitivity of 5%. However, a more important statistic is the
positive predictive value (PPV), the proportion who are readmitted among those who are
identified as at risk for readmission. The PPV was 57.4%, much better than 9.5%.
Strengths and Limitations of the Study
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This study has some strengths and limitations. This research study utilized a
large sample of three years of data to identify important readmission factors and to develop
and test a predictive model for readmission. This is the first study to explore 30-day
readmissions solely among Hispanic adults with type 2 diabetes. No other study has used
such a large sample of a specific minority population. It provides evidence that the LACE
model for predicting 30-day readmission among this specific population is not useful and in
particular, the acuity variable may not indicate severity within the present U.S. health care
structure but particularly for a hospital serving a large Hispanic population. The citizenship
status of participants in this cohort is unknown but given the high probability for mixed
status, and evidence that regardless of status, Hispanics may prefer using the ED over care in
a primary care office, ED use may be a proxy for lack of a regular primary care provider, and
not acuity. However, the number of ED visits in the prior 6 months was the factors associated
with the highest increased odds of readmission.
Limitations of study include a fairly low re-admission rate, 9.5%, among the study
cohort when compared to other published rates. There was also a trend toward decreased readmission during the three study years, indicating the hospital had initiated successful efforts
to decrease readmission among patients with diabetes that included introduction of diabetes
nurse practitioners. Having a diabetes nurse practitioner see the patient was not associated
with reduced readmission but this could be due to the fact that they saw 70% of the study
participants. Additionally, for the predictive modelling of the Hispanic Diabetic Study and
the model adding ED visits, 19% of subject were missing at least one of the variables
although for the LACE variables less had 1% of subjects had missing variables.
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The data from this retrospective study relied primarily on routinely collected
administrative and clinical data and therefore, was unable to capture finer classification of
study concepts such as ethnicity or social determinants of health. For example, the cultural
backgrounds of the Hispanic in the study cohort could not be classified as HispanicMexicans or; Hispanic-Puerto Ricans. Some studies have found education level and health
literacy to be important in readmission (Bailey et al., 2015) but these variables were not
available. Additionally, it is unclear exactly how the language variable was asked. Does it
mean Spanish-speaking only or preferred language is Spanish? This study was unable to
explore other potentially important social determinants of health such as neighborhood due to
validity issues with given address zip codes or other variables such as home ownership.
Implications for Nursing and Nursing Education
The rate of diabetes has exponentially increased in the United States in the past
decades. Hispanics have lowest health insurance coverage and as a result are less likely to
receive care from usual sources (Weinick, Jacobs, Stone, Ortega, & Burstin, 2004). Fiftyseven percent of undocumented Hispanic immigrants have barriers to healthcare (Ortega,
Rodriguez, & Vargas Bustamante, 2015; Vargas Bustamante, et al., 2012).
Hispanics, in comparison to other Americans, have less access to high quality evidence-based
care for management of chronic diseases like diabetes (Ortega, Rodriguez, and Vargas
Bustamante, 2015).
The rate of Hispanic nurses in the workforce has slowly increased from 3.4% in 2013
to 5.3% in 2017 (Smiley et al. 2018) which is considerably below the national proportion of
Hispanics of 18% or the 28% in California. It is crucial that targeted efforts to recruit and
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retain continue in order to achieve better language-concordant care which hopefully will lead
to improve outcomes in this population.
It is important that future nurses be trained not only for general nursing care, but also
for specific chronic care management during their nursing curriculum to help meet the care
needs of a growing population of diabetic patients. The numbers of Hispanic adults with
diabetes is increasing.
Increased use of nurse practitioners in the hospital and specially to work with patients
with chronic conditions, like those with diabetes, advanced lung disease like COPD and CHF
improves patient care ( Holstein, B.A. 2018; Li et al 2017). Their ability to diagnose and
prescribe provides them a unique advantage, and because they come from the nursing
philosophy of care, they view care provision with holistic approach which incorporates not
only the spiritual and emotional spheres in addition to the physical one but also the larger
social context of patients lives including their family and community ( Sangster-Gormley,
Frisch , & Schreiber, 2013). The role of nursing in the care of those with diabetes ranges
from bedside care of basic needs, like improved blood glucose levels and teaching, to
communicating with the physician or diabetes nurse practitioner. Recognizing patients’
diabetes self-care weakness and strengths on day one of admission expedites care for these
patients. Utilizing nurse case managers, diabetes nurse educators, and home health nurses
improves care quality and patient satisfaction. Precise diabetes medications reconciliation is a
delicate job that improves the discharge process, decreases length of stay and helps decrease
30-day readmission among diabetic patients (Drincic, Pfeffer, Luo, & Goldner, 2017).
Recommendations for Nursing Research
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This study was unique in its examination of different factors related to 30-day
readmission among Hispanic adults with type 2 diabetes. The study hospital had a unique
model of including diabetes nurse practitioners as part of the care team and they may have
played a role to the low readmission among Hispanic with diabetes. Further research should
be aimed at examining the effectiveness of diabetes nurse practitioners to improve patient
care outcomes, patient satisfaction, and reduce 30-day readmission rates, objectives that
could not be accomplished by this study.
Another area to explore is to confirm the strength of the relationship between number
of ED visits in the prior 6 months and readmission and explore the meaning of this variable.
Is it a marker for the lack of a regular primary care provider or something else? Are the
forces in using the ED purely financial? Once these are known then, interventions aimed at
the sources of ED use may be effective when someone on admission has been ideated as
using the ED one or more time in the past six months.
Advances in technology and in hospitals abilities to collect data, have made this an
exciting time for nursing research. Meaningful studies that use already collected data from
hospital financial and electronic medical records may generate predictive models to decrease
30-day readmission using more sophisticated analytic approaches beyond the scope of this
study, such as neural networks and machine learning (Jamei et al, 2017; Min, Yu, & Wang,
2019). At minimum, if severity of illness is an important predictor of readmission,
researchers should explore a better proxy variable, other than admission from the ED in
healthcare situations where the ED is the primary route to admission for all patients. Lastly,
it would be possible to use the Hispanic Diabetic Study + ED visits prospectively to identify
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patients on admission at higher risk for readmission and test whether the provision of more
targeted interventions at these individuals reduced readmission.
Policy Implications
The changing Hispanics demographics in the United States presents a number of
challenges to health care policy makers, clinicians, organizations, and other stakeholders.
Studies have demonstrated that Hispanics tend to have worse patterns of access to, and
utilization of, health care than other ethnic and racial groups. Under the Affordable Care Act
(ACA) 95% of uninsured Hispanics qualified for Medicaid or tax credits by 2015 (US Dept.
Health Hum. Serv., 2014). In fact, between 2013 and 2017, Hispanic adults between the ages
of 19 to 64 had the highest absolute decrease in the gap of percent uninsured compared to
non-Hispanic whites from 25.4% to 16.5% points (Chaudry, Jackson & Glied, 2019). The
implementation of the Affordable Care Act (ACA) of 2010 may have ameliorated some of
these disparities. However, even with the ACA, it is expected that Hispanic will continue to
have problems accessing and using high-quality health care, especially in states that are not
expanding Medicaid eligibility as provided by the ACA. I identify four current policy
dilemmas relevant to Hispanic’ health and ACA implementation. First, there is a need to
provide primary care services for those with undocumented citizenship status. This requires a
policy solution for those who have lived and worked in the U.S. for many years without legal
status. The financing of primary care through emergency rooms makes no fiscal sense and it
detrimental to the needed continuity of care of improve disease management of those with
chronic illnesses, such as diabetes. Secondly, even for those individuals who are here legally,
the current suggests changes to the ‘public charge’ regulations may encourage these
individuals to refuse public health insurance they are entitled and eligible for out of fear
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accepting it will jeopardize their ability to become citizens. Lastly, there is a need to increase
the diversity of the healthcare workforce especially with individuals with a Hispanic
background in order to improve linguistic and culturally congruent care to this fastest
growing segment of the American population.
Conclusion
Diabetes care is complex, particularly in the hospital setting. It requires a team of
experts from when the patient arrives at the hospital until the time, they return home in order
to ensure the patient receives the best possible care and practices but also to reduce
readmissions which are costly both to patients, families, and health care system.
This study investigated predictive factors contributing to 30-day readmissions among
Hispanic adults with type 2 diabetes. It identified sociodemographic factors found in other
studies as well as the intuitively obvious factor of increased length of stay as predictors.
However, it did not confirm that identified spoken language of Spanish was a large predictor
for readmission. It did find that the addition of a simple question or data point, the number of
times the patient was seen in the emergency department in the last 6 months, may be most
crucial to potentially preventing readmission. This study’s findings contribute additional
understanding of 30-day hospital readmissions among Hispanic patients with type 2 diabetes.
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